Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bladder Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    July 2022
  1. XIAO H, Li H, Yu G, Xiao W, et al
    [Corrigendum] MicroRNA10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    February 2022
  2. GAO X, Liu J, Fan D, Li X, et al
    Berberine enhances gemcitabineinduced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    August 2021
  3. HUANG J, He QM, Wu Q, Zhou WM, et al
    Long noncoding RNA 00858 knockdown alleviates bladder cancer via regulation of the miR30645p/CTGF axis.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    April 2021
  4. CHEN X, Chen S
    LINC00649 promotes bladder cancer malignant progression by regulating the miR15a5p/HMGA1 axis.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available


    March 2021
  5. JIA M, Su B, Mo L, Qiu W, et al
    Circadian clock protein CRY1 prevents paclitaxelinduced senescence of bladder cancer cells by promoting p53 degradation.
    Oncol Rep. 2021;45:1033-1043.
    PubMed     Abstract available


  6. CHOU KY, Chang AC, Tsai TF, Lin YC, et al
    MicroRNA34a5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase2 silencing.
    Oncol Rep. 2021;45:911-920.
    PubMed     Abstract available


    January 2021
  7. LI S, Zhao Y, Chen X
    Microarray expression profile analysis of circular RNAs and their potential regulatory role in bladder carcinoma.
    Oncol Rep. 2021;45:239-253.
    PubMed     Abstract available


    November 2020
  8. CHEN Y, Xu T, Xie F, Wang L, et al
    Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7853.
    PubMed     Abstract available


  9. ZHANG Z, Chen F, Zhan H, Chen L, et al
    lncRNA CASC9 sponges miR7583p to promote proliferation and EMT in bladder cancer by upregulating TGFbeta2.
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7852.
    PubMed     Abstract available


  10. SHEN C, Wang Y, Wu Z, Da, et al
    Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
    Oncol Rep. 2020;44:1831-1850.
    PubMed     Abstract available


    April 2020
  11. VALLO S, Stege H, Berg M, Michaelis M, et al
    Tumor necrosis factorrelated apoptosisinducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against firstline chemotherapy.
    Oncol Rep. 2020;43:1331-1337.
    PubMed     Abstract available


    February 2020
  12. LIU J, Zhao Z, Sun Z, Liu C, et al
    Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation.
    Oncol Rep. 2020;43:562-570.
    PubMed     Abstract available


    December 2019
  13. YIN H, Zhang C, Gou X, He W, et al
    Identification of a 13mRNA signature for predicting disease progression and prognosis in patients with bladder cancer.
    Oncol Rep. 2019 Dec 12. doi: 10.3892/or.2019.7429.
    PubMed     Abstract available


    September 2019
  14. JOU YC, Wang SC, Dai YC, Chen SY, et al
    Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
    Oncol Rep. 2019;42:1005-1016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: